Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Khader

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
JCI Insight|October 6, 2017
Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosisRacquel Domingo-Gonzalez, Shibali Das, Kristin L Griffiths, et al.
Nature|July 25, 2019
Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosisAmanda Ardain, Racquel Domingo-Gonzalez, Shibali Das, et al.
Nature|June 7, 2019
Group 3 innate lymphoid cells mediate early protective immunity against tuberculosisAmanda Ardain, Racquel Domingo-Gonzalez, Shibali Das, et al.
Frontiers in Immunology|May 31, 2021
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|March 15, 2021
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|May 17, 2021
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, et al.
Nature Microbiology|December 19, 2020
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosetsDhiraj Kumar Singh, Bindu Singh, Shashank R Ganatra, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
JCI Insight|October 6, 2017
Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosisRacquel Domingo-Gonzalez, Shibali Das, Kristin L Griffiths, et al.
Nature|July 25, 2019
Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosisAmanda Ardain, Racquel Domingo-Gonzalez, Shibali Das, et al.
Nature|June 7, 2019
Group 3 innate lymphoid cells mediate early protective immunity against tuberculosisAmanda Ardain, Racquel Domingo-Gonzalez, Shibali Das, et al.
Frontiers in Immunology|May 31, 2021
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|March 15, 2021
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical OutcomeJose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
The Journal of Infectious Diseases|March 5, 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, et al.
Frontiers in Immunology|May 17, 2021
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz-Lagunas, et al.
Nature Microbiology|December 19, 2020
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosetsDhiraj Kumar Singh, Bindu Singh, Shashank R Ganatra, et al.
Pageof 20